The stabilized PTEN inhibited the proliferation of ccRCC cells by suppressing the PI3K/AKT and TNF-alpha/NF-kB signaling pathways, and at the same time, enhanced the sensitivity of cancer cells to tyrosine kinase inhibitors (TKIs). This evidence concerns the gene TNF and nonpapillary renal cell carcinoma.